Johnson & Johnson Takes Control Of Vaccine Plant

The transcript discusses issues with COVID vaccine manufacturing, leading to the government placing Johnson & Johnson in charge of a Baltimore facility. AstraZeneca is being phased out due to approval issues in the US, and is seeking new manufacturing locations. Despite these changes, Johnson & Johnson commits to delivering 100 million vaccine doses to the US by the end of May.

What was the reason for the government putting Johnson and Johnson in charge of the Baltimore facility?

• To reduce costs

• To improve vaccine efficacy

• To prevent future mix-ups

• To increase production speed

Why is Astra Zeneca being pushed out of the Baltimore facility?

• They completed their contract

• They requested to leave

• Their vaccine is not approved in the US

• Their vaccine is not effective

What is Astra Zeneca currently working on with the US?

• Increasing vaccine efficacy

• Finding a new manufacturing location

• Reducing vaccine costs

• Improving distribution channels

How many doses does Johnson and Johnson plan to deliver to the US by the end of May?

• 100 million

• 75 million

• 150 million

• 50 million

Despite the manufacturing setback, what is Johnson and Johnson's commitment?

• To open a new facility

• To partner with Astra Zeneca

• To deliver 100 million doses by the end of May

• To develop a new vaccine